Dividend Stocks To Watch Now – April 27th

ProShares UltraPro Short QQQ, Direxion Daily TSLA Bull 2X Shares, Merck & Co., Inc., AbbVie, PepsiCo, Gilead Sciences, and Texas Instruments are the seven Dividend stocks to watch today, according to MarketBeat’s stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). These companies had the highest dollar trading volume of any Dividend stocks within the last several days.

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

Shares of SQQQ traded down $1.07 during midday trading on Friday, hitting $31.65. 108,625,712 shares of the company’s stock traded hands, compared to its average volume of 49,633,731. ProShares UltraPro Short QQQ has a 1 year low of $26.21 and a 1 year high of $61.60. The firm’s fifty day moving average is $36.54 and its 200-day moving average is $33.19.

Direxion Daily TSLA Bull 2X Shares (TSLL)

Shares of TSLL stock traded up $1.71 during trading hours on Friday, reaching $10.45. 264,295,819 shares of the company’s stock were exchanged, compared to its average volume of 83,918,849. The stock has a market cap of $5.41 billion, a PE ratio of 48.19 and a beta of -5.14. The stock’s fifty day moving average price is $10.26 and its two-hundred day moving average price is $18.27. Direxion Daily TSLA Bull 2X Shares has a 1 year low of $6.29 and a 1 year high of $41.50.

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

Merck & Co., Inc. stock traded up $2.99 during mid-day trading on Friday, reaching $82.83. 28,374,477 shares of the company traded hands, compared to its average volume of 11,908,288. The firm’s fifty day moving average is $87.05 and its two-hundred day moving average is $95.13. The company has a market capitalization of $208.88 billion, a price-to-earnings ratio of 12.31, a price-to-earnings-growth ratio of 0.77 and a beta of 0.40. Merck & Co., Inc. has a fifty-two week low of $75.93 and a fifty-two week high of $134.63. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.36 and a quick ratio of 1.15.

AbbVie (ABBV)

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

Shares of NYSE ABBV traded up $5.59 during mid-day trading on Friday, hitting $185.96. The stock had a trading volume of 10,480,961 shares, compared to its average volume of 6,045,510. The company has a 50 day moving average of $196.85 and a two-hundred day moving average of $187.18. AbbVie has a twelve month low of $153.58 and a twelve month high of $218.66. The company has a debt-to-equity ratio of 17.94, a quick ratio of 0.55 and a current ratio of 0.66. The firm has a market cap of $328.96 billion, a PE ratio of 77.48, a PEG ratio of 1.62 and a beta of 0.55.

PepsiCo (PEP)

PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region.

Shares of NASDAQ:PEP traded down $1.93 during trading on Friday, hitting $133.38. The stock had a trading volume of 11,537,466 shares, compared to its average volume of 6,152,649. The stock has a 50-day simple moving average of $147.70 and a two-hundred day simple moving average of $153.79. The stock has a market capitalization of $182.91 billion, a price-to-earnings ratio of 19.19, a price-to-earnings-growth ratio of 3.09 and a beta of 0.49. PepsiCo has a 12-month low of $131.80 and a 12-month high of $183.41. The company has a quick ratio of 0.65, a current ratio of 0.82 and a debt-to-equity ratio of 2.05.

Gilead Sciences (GILD)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.

NASDAQ GILD traded down $2.98 on Friday, hitting $103.17. 14,207,970 shares of the company’s stock traded hands, compared to its average volume of 7,506,787. The firm’s 50-day moving average price is $109.21 and its two-hundred day moving average price is $98.24. The firm has a market capitalization of $128.46 billion, a PE ratio of 278.84, a P/E/G ratio of 0.71 and a beta of 0.32. The company has a current ratio of 1.50, a quick ratio of 1.20 and a debt-to-equity ratio of 1.24. Gilead Sciences has a 1-year low of $62.07 and a 1-year high of $119.96.

Texas Instruments (TXN)

Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers in the United States and internationally. The company operates through Analog and Embedded Processing segments. The Analog segment offers power products to manage power requirements across various voltage levels, including battery-management solutions, DC/DC switching regulators, AC/DC and isolated controllers and converters, power switches, linear regulators, voltage references, and lighting products.

Shares of Texas Instruments stock traded up $0.73 during trading on Friday, hitting $162.86. 8,381,928 shares of the company’s stock were exchanged, compared to its average volume of 6,193,889. The business has a 50-day simple moving average of $174.21 and a 200-day simple moving average of $187.70. The stock has a market capitalization of $148.19 billion, a price-to-earnings ratio of 31.38, a PEG ratio of 3.30 and a beta of 0.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.88 and a current ratio of 4.12. Texas Instruments has a 52-week low of $139.95 and a 52-week high of $220.39.